The FDA announced that state-licensed pharmacists can now prescribe the COVID-19 treatment Paxlovid with some limitations.
Paxlovid (nirmatrelvir/ritonavir; Pfizer) received emergency use authorization (EUA) from the FDA in December, becoming the first oral antiviral treatment for COVID-19.
In March, President Joe Biden announced a test-to-treat initiative that allowed select pharmacies to provide antiviral treatment to patients who test positive for COVID-19 on the spot at no cost. However, the American Society of Health-System Pharmacists (ASHP) noted that, because of the specific language in